2025 second_quarter Filing
Q2Lobbying Activities
Medication affordability and access; general diabetes prevention. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN. 340B.
Support for obesity drug coverage and access.